VONENTIAL

What this means for you

This application is over — abandoned 13 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88160468

Mark type

Stylized text

Filed

18 Oct 2018

Published for opposition

12 Mar 2019

Abandoned

13 Jun 2022

Attorney of record

Andrea Christensen

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Owner

• Agouron Pharmaceuticals, LLC, San Diego, CA, US
• Agouron Pharmaceuticals, LLC, San Diego, CA, US

Prosecution history

• 13 Jun 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 13 Jun 2022 — ABANDONMENT - NO USE STATEMENT FILED
• 23 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 22 Oct 2021 — SOU EXTENSION 5 GRANTED
• 14 Oct 2021 — SOU EXTENSION 5 FILED
• 22 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 14 Oct 2021 — SOU TEAS EXTENSION RECEIVED
• 09 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 07 Apr 2021 — SOU EXTENSION 4 GRANTED
• 07 Apr 2021 — SOU EXTENSION 4 FILED
• 07 Apr 2021 — SOU TEAS EXTENSION RECEIVED
• 02 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 30 Sept 2020 — SOU EXTENSION 3 GRANTED
• 30 Sept 2020 — SOU EXTENSION 3 FILED
• 30 Sept 2020 — SOU TEAS EXTENSION RECEIVED